Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism LATS1 inhibitors(large tumor suppressor kinase 1 inhibitors), LATS2 inhibitors(large tumor suppressor kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H21N3O4 |
InChIKeyFBCPIOAXERAOIA-UHFFFAOYSA-N |
CAS Registry2351906-74-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | JP | 01 Apr 2022 |